Medtronic reported Q1 2025 revenue of $8.3B, missed analyst consensus of $8.3B by $35.4M. Diluted EPS came in at $1.39, beat the $1.36 consensus by $0.03. Medtronic reports across 4 business segments, led by Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio.
Trailing eight quarters through Q1 2025
Common questions about Medtronic's Q1 2025 earnings report.
Medtronic (MDT) reported Q1 2025 earnings on February 18, 2025 before market open.
Medtronic reported revenue of $8.3B and diluted EPS of $1.39 for Q1 2025.
Revenue missed the consensus estimate of $8.3B by $35.4M. EPS beat the consensus estimate of $1.36 by $0.03.
You can read the 10-Q periodic report (0001613103-25-000022) directly on SEC EDGAR. The filing index links above go to sec.gov.